Extracellular fluid volume is associated with incident end-stage kidney disease and mortality in patients with chronic kidney disease.


Journal

Kidney international
ISSN: 1523-1755
Titre abrégé: Kidney Int
Pays: United States
ID NLM: 0323470

Informations de publication

Date de publication:
10 2019
Historique:
received: 22 02 2019
revised: 14 05 2019
accepted: 07 06 2019
pubmed: 4 9 2019
medline: 21 10 2020
entrez: 4 9 2019
Statut: ppublish

Résumé

Volume overload has been shown to be an independent risk factor for mortality in patients receiving chronic dialysis, but data in non-dialysis patients are scarce. Therefore we evaluated the prognostic value of extracellular fluid (ECF) volume for chronic kidney disease (CKD) progression and mortality in a prospective hospital-based cohort with CKD stage 1-4 (NephroTest Study). ECF (scaled to body surface area) and the measured glomerular filtration rate (mGFR) were determined using the distribution volume and clearance of 51Cr-EDTA, respectively. Cause-specific Cox and linear mixed-effect regression models were used to analyze the association of ECF with end-stage kidney disease (ESKD) and mortality, and with mGFR decline, respectively. The 1593 patients were mean age 58.8 years, 67% were men, mean mGFR of 43.6 mL/min/1.73m

Identifiants

pubmed: 31477263
pii: S0085-2538(19)30704-5
doi: 10.1016/j.kint.2019.06.017
pii:
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1020-1029

Investigateurs

François Vrtovsnik (F)
Eric Daugas (E)
Nahid Tabibzadeh (N)
Martin Flamant (M)
Emmanuelle Vidal-Petiot (E)
Alexandre Karras (A)
Stéphane Roueff (S)
Eric Thervet (E)
Pascal Houillier (P)
Marie Courbebaisse (M)
Caroline Prot-Bertoye (C)
Jean-Philippe Bertocchio (JP)
Gérard Maruani (G)
Jean-Jacques Boffa (JJ)
Pierre Ronco (P)
Hafedh Fessi (H)
Eric Rondeau (E)
Marine Livrozet (M)
Emmanuel Letavernier (E)
Jean-Philippe Haymann (JP)
Marie Metzger (M)
Pablo Urena-Torres (P)
Bénédicte Stengel (B)

Informations de copyright

Copyright © 2019 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Auteurs

Anne-Laure Faucon (AL)

Centre de recherche en Epidémiologie et Santé des Populations, INSERM U1018, Paris-Sud University, Villejuif, France.

Martin Flamant (M)

Université de Paris, Paris, France; Department of Physiology, Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Paris, France; INSERM U1149, Centre de recherche sur l'inflammation, Paris, France.

Marie Metzger (M)

Centre de recherche en Epidémiologie et Santé des Populations, INSERM U1018, Paris-Sud University, Villejuif, France.

Jean-Jacques Boffa (JJ)

Department of Nephrology, Assistance Publique-Hôpitaux de Paris, Hôpital Tenon, Paris, France; Pierre et Marie Curie University, Paris, France.

Jean-Philippe Haymann (JP)

Pierre et Marie Curie University, Paris, France; Department of Physiology, Assistance Publique-Hôpitaux de Paris, Hôpital Tenon, Paris, France.

Pascal Houillier (P)

Université de Paris, Paris, France; Department of Physiology, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France; INSERM UMRS 1138, Centre de Recherche des Cordeliers, Paris, France.

Eric Thervet (E)

Université de Paris, Paris, France; Department of Nephrology, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France.

François Vrtovsnik (F)

Université de Paris, Paris, France; Department of Nephrology, Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Paris, France.

Bénédicte Stengel (B)

Centre de recherche en Epidémiologie et Santé des Populations, INSERM U1018, Paris-Sud University, Villejuif, France.

Guillaume Geri (G)

Centre de recherche en Epidémiologie et Santé des Populations, INSERM U1018, Paris-Sud University, Villejuif, France; Medical Intensive Care Unit, Assistance Publique-Hôpitaux de Paris, Hôpital Ambroise Paré, Boulogne-Billancourt, France; Versailles Saint Quentin University, Versailles, France.

Emmanuelle Vidal-Petiot (E)

Université de Paris, Paris, France; Department of Physiology, Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Paris, France; INSERM U1149, Centre de recherche sur l'inflammation, Paris, France. Electronic address: emmanuelle.vidal-petiot@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH